June 10, 2017
Spartoo élargit son portefeuille de marques propres

 
May 30, 2017
Molecular Partners provides additional details on clinical studies of proprietary lead oncology asset MP0250

 
May 12, 2017
Patrick Amstutz Appointed as Chief Executive Officer

 
April 6, 2017
Molecular Partners discloses change in shareholder base

 
March 30, 2017
Symetis and Boston Scientific reach USD 435 million purchase agreement

 
more...
© Endeavour Vision SA 2006-2017 Terms & Conditions